Janin Yves. 2022. « On drug discovery against infectious diseases and academic medicinal chemistry contributions ». Beilstein Journal of Organic Chemistry 18 (janvier). Beilstein-Institut; {Beilstein-Institut}: 1355-78. doi:10.3762/bjoc.18.141.
Janin Yves. 2022. « Analogues of a luciferin of marine origin, few chemistry contributions ». In 21s International Symposium on Bioluminescence and Chemiluminescence. https://hal.science/hal-03932359.
Takatsu Kyoko, Kobayashi Naohiro, Wu Nan, Janin Yves, Yamazaki Toshio, et Kuroda Yutaka. 2023. « Biophysical analysis of Gaussia luciferase bioluminescence mechanisms using a non-oxidizable coelenterazine ». BBA Advances 3 (janvier). Elsevier: 100068. doi:10.1016/j.bbadva.2022.100068.
Janin Yves. 2023. « On the origins of SARS-CoV-2 main protease inhibitors ». RSC Medicinal Chemistry, octobre. Royal Society of Chemistry. doi:10.1039/D3MD00493G.
Gao. Tadeja, Damborsky. Jiri, Janin Yves, et Marek. Martin. 2023. « Deciphering Enzyme Mechanisms with Engineered Ancestors and Substrate Analogues ». ChemCatChem 15 (août). Wiley. doi:10.1002/cctc.202300745.
, octobre 2023 — Illuminating the mechanism and allosteric behavior of NanoLuc luciferase. , , working paper or preprint
Krämer Andreas, Tjaden Amelie, Ndreshkjana Benardina, Tredup Claudia, Farin Henner, Knapp Stefan, Janin Yves, et Müller Susanne. 2022. « IPP/CNRS-A017: A chemical probe for human dihydroorotate dehydrogenase (hDHODH) ». Current Research in Chemical Biology 2 (janvier): 100034. doi:10.1016/j.crchbi.2022.100034.
Legrand Pierre, et Janin Yves. 2022. « On Reuben G. Jones synthesis of 2-hydroxypyrazines ». Beilstein Journal of Organic Chemistry. Beilstein-Institut; {Beilstein-Institut}. doi:10.3762/bjoc.18.93.